1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Scleroderma, Limited: new trials by email Literature Review of Scleroderma, Limited trials Research Report on Scleroderma, Limited
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease hyaluronidase injected intradermally - Microstomia, Scleroderma | Early Phase 1 | Withdrawn | Brigham and Women's Hospital | 2020-01-01 | 2021-01-14 |
CREST Syndrome (1) · Microstomia (1) · Scleroderma, Diffuse (1) · Scleroderma, Localized (1) · Scleromyxedema (1)
Calcinosis (1) · Calcium Metabolism Disorders (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Embolism and Thrombosis (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gastrointestinal Diseases (1) · Livedoid Vasculopathy (1) · Metabolic Diseases (1) · Mouth Abnormalities (1)